If Patients Know Best, then Patient Social Networks Can Help Capture and Report AEs
A recent article published in the New York Times caught my attention. The article -- "In Reporting Symptoms, Don’t Patients Know Best?" (find it...
New Omnaris TV Ad is Less Freudian, Still Amateurish
There are plenty of negative comments on various Internet forums about the first generation of Omnaris TV commercials, which began to air last year....
The iPad as a Pharma Marketing Platform
"DTC marketers can't afford the luxury of waiting to see how many people purchase an iPad they have to start experimenting with app development...
An Analysis of DDMAC Warning Letters Regarding Risk Information in Broadcast Drug Ads
The FDA Amendments Act (FDAAA), which was signed into law in 2007, requires that the FDA issue new regulations regarding the presentation of risk...
Pfizer Reveals (Almost) All Payments to Physicians
Pfizer recently published its list of physician payments it made during the last half of 2009 (Q3 and Q4). The list, which is presented...
WLF & Pfizer Ask Court to Block FDA Guidance on Social Media
Yesterday, in a move that is sure to delay if not completely halt FDA efforts to issue guidance on the regulation of drug promotion...
Use of Social Media for Health Purposes in the EU
This article is a summary of the EPG Health Media (part of the IMR International Group) market research report 'Social Media and Healthcare,' which examines how European doctors, patients/consumers and pharma engage (and seek to engage) with each other.
Moderation Best Practices for Pharma Social Networks
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices.
How to Manage the Online Conversation
This article presents a summary of a conversation with Jenna Woodul, LiveWorld's EVP and Chief Community Officer, about how pharma companies can manage their social media interactions using technology and credentialed participants.
Real Patient Testimonials
This article discusses the potential pitfalls, regulatory issues, and best practices regarding the use of real patient testimonials based on comments collected from a recent survey of readers and other experts.
